Prostaglandin E2 induces IL-6 and IL-8 production by the EP Receptors/Akt/NF-ΚB pathways in nasal polyp-derived fibroblasts

Jung Sun Cho, In Hye Han, Hye Rim Lee, Heung Man Lee

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Interleukin 6 (IL-6) and IL-8 participate in the pathogenesis of chronic rhinosinusitis with nasal polyps, and their levels are increased by prostaglandin E2 (PGE2) in different cell types. The purposes of this study were to determine whether PGE2 has any effect on the increase in the levels of IL-6 and IL-8 in nasal polyp-derived fibroblasts (NPDFs) and subsequently investigate the possible mechanism of this effect. Methods: Different concentrations of PGE2 were used to stimulate NPDFs at different time intervals. NPDFs were treated with agonists and antagonists of E prostanoid (EP) receptors. To determine the signaling pathway for the expression of PGE2-induced IL-6 and IL-8, PGE2 was treated with Akt and NF-ΚB inhibitors in NPDFs. Reverse transcription-polymerase chain reaction for IL-6 and IL-8 mRNAs was performed. IL-6 and IL-8 levels were measured byenzyme-linked immunosorbent assay (ELISA). The activation of Akt and NF-ΚB was evaluated by western blot analysis. Results: PGE2 significantly increased the mRNA and protein expression levels of IL-6 and IL-8 in NPDFs. The EP2 and EP4 agonists and antagonists induced and inhibited IL-6 expression. However, the EP4 agonist and antagonist were only observed to induce and inhibit IL-8 expression level. The Akt and NF-ΚB inhibitors significantly blocked PGE2-induced expression of IL-6 and IL-8. Conclusions: PGE2 increases IL-6 expression via EP2 and EP4 receptors, and IL-8 expression via the EP4 receptor in NPDFs. It also activates the Akt and NF-ΚB signal pathways for the production of IL-6 and IL-8 in NPDFs. These results suggest that signaling pathway for IL-6 and IL-8 expression induced by PGE2 might be a useful therapeutic target for the treatment of nasal polyposis.

Original languageEnglish
Pages (from-to)449-457
Number of pages9
JournalAllergy, Asthma and Immunology Research
Volume6
Issue number5
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Nasal Polyps
Interleukin-8
Dinoprostone
Prostaglandins
Interleukin-6
Fibroblasts
Interleukin-8 Receptors
Immunosorbents
Messenger RNA
Nose
Reverse Transcription
Signal Transduction
Western Blotting
Enzyme-Linked Immunosorbent Assay

Cite this

Prostaglandin E2 induces IL-6 and IL-8 production by the EP Receptors/Akt/NF-ΚB pathways in nasal polyp-derived fibroblasts. / Cho, Jung Sun; Han, In Hye; Lee, Hye Rim; Lee, Heung Man.

In: Allergy, Asthma and Immunology Research, Vol. 6, No. 5, 01.01.2014, p. 449-457.

Research output: Contribution to journalArticle

@article{bbf263e145f14e8fa18a69f7438c9bec,
title = "Prostaglandin E2 induces IL-6 and IL-8 production by the EP Receptors/Akt/NF-ΚB pathways in nasal polyp-derived fibroblasts",
abstract = "Interleukin 6 (IL-6) and IL-8 participate in the pathogenesis of chronic rhinosinusitis with nasal polyps, and their levels are increased by prostaglandin E2 (PGE2) in different cell types. The purposes of this study were to determine whether PGE2 has any effect on the increase in the levels of IL-6 and IL-8 in nasal polyp-derived fibroblasts (NPDFs) and subsequently investigate the possible mechanism of this effect. Methods: Different concentrations of PGE2 were used to stimulate NPDFs at different time intervals. NPDFs were treated with agonists and antagonists of E prostanoid (EP) receptors. To determine the signaling pathway for the expression of PGE2-induced IL-6 and IL-8, PGE2 was treated with Akt and NF-ΚB inhibitors in NPDFs. Reverse transcription-polymerase chain reaction for IL-6 and IL-8 mRNAs was performed. IL-6 and IL-8 levels were measured byenzyme-linked immunosorbent assay (ELISA). The activation of Akt and NF-ΚB was evaluated by western blot analysis. Results: PGE2 significantly increased the mRNA and protein expression levels of IL-6 and IL-8 in NPDFs. The EP2 and EP4 agonists and antagonists induced and inhibited IL-6 expression. However, the EP4 agonist and antagonist were only observed to induce and inhibit IL-8 expression level. The Akt and NF-ΚB inhibitors significantly blocked PGE2-induced expression of IL-6 and IL-8. Conclusions: PGE2 increases IL-6 expression via EP2 and EP4 receptors, and IL-8 expression via the EP4 receptor in NPDFs. It also activates the Akt and NF-ΚB signal pathways for the production of IL-6 and IL-8 in NPDFs. These results suggest that signaling pathway for IL-6 and IL-8 expression induced by PGE2 might be a useful therapeutic target for the treatment of nasal polyposis.",
keywords = "Akt, E prostanoid receptor, Interleukin-6, Interleukin-8, Nasal polyps, Prostaglandins E",
author = "Cho, {Jung Sun} and Han, {In Hye} and Lee, {Hye Rim} and Lee, {Heung Man}",
year = "2014",
month = "1",
day = "1",
doi = "10.4168/aair.2014.6.5.449",
language = "English",
volume = "6",
pages = "449--457",
journal = "Allergy, Asthma and Immunology Research",
issn = "2092-7355",
publisher = "Korean Academy of Asthma, Allergy and Clinical Immunology",
number = "5",

}

TY - JOUR

T1 - Prostaglandin E2 induces IL-6 and IL-8 production by the EP Receptors/Akt/NF-ΚB pathways in nasal polyp-derived fibroblasts

AU - Cho, Jung Sun

AU - Han, In Hye

AU - Lee, Hye Rim

AU - Lee, Heung Man

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Interleukin 6 (IL-6) and IL-8 participate in the pathogenesis of chronic rhinosinusitis with nasal polyps, and their levels are increased by prostaglandin E2 (PGE2) in different cell types. The purposes of this study were to determine whether PGE2 has any effect on the increase in the levels of IL-6 and IL-8 in nasal polyp-derived fibroblasts (NPDFs) and subsequently investigate the possible mechanism of this effect. Methods: Different concentrations of PGE2 were used to stimulate NPDFs at different time intervals. NPDFs were treated with agonists and antagonists of E prostanoid (EP) receptors. To determine the signaling pathway for the expression of PGE2-induced IL-6 and IL-8, PGE2 was treated with Akt and NF-ΚB inhibitors in NPDFs. Reverse transcription-polymerase chain reaction for IL-6 and IL-8 mRNAs was performed. IL-6 and IL-8 levels were measured byenzyme-linked immunosorbent assay (ELISA). The activation of Akt and NF-ΚB was evaluated by western blot analysis. Results: PGE2 significantly increased the mRNA and protein expression levels of IL-6 and IL-8 in NPDFs. The EP2 and EP4 agonists and antagonists induced and inhibited IL-6 expression. However, the EP4 agonist and antagonist were only observed to induce and inhibit IL-8 expression level. The Akt and NF-ΚB inhibitors significantly blocked PGE2-induced expression of IL-6 and IL-8. Conclusions: PGE2 increases IL-6 expression via EP2 and EP4 receptors, and IL-8 expression via the EP4 receptor in NPDFs. It also activates the Akt and NF-ΚB signal pathways for the production of IL-6 and IL-8 in NPDFs. These results suggest that signaling pathway for IL-6 and IL-8 expression induced by PGE2 might be a useful therapeutic target for the treatment of nasal polyposis.

AB - Interleukin 6 (IL-6) and IL-8 participate in the pathogenesis of chronic rhinosinusitis with nasal polyps, and their levels are increased by prostaglandin E2 (PGE2) in different cell types. The purposes of this study were to determine whether PGE2 has any effect on the increase in the levels of IL-6 and IL-8 in nasal polyp-derived fibroblasts (NPDFs) and subsequently investigate the possible mechanism of this effect. Methods: Different concentrations of PGE2 were used to stimulate NPDFs at different time intervals. NPDFs were treated with agonists and antagonists of E prostanoid (EP) receptors. To determine the signaling pathway for the expression of PGE2-induced IL-6 and IL-8, PGE2 was treated with Akt and NF-ΚB inhibitors in NPDFs. Reverse transcription-polymerase chain reaction for IL-6 and IL-8 mRNAs was performed. IL-6 and IL-8 levels were measured byenzyme-linked immunosorbent assay (ELISA). The activation of Akt and NF-ΚB was evaluated by western blot analysis. Results: PGE2 significantly increased the mRNA and protein expression levels of IL-6 and IL-8 in NPDFs. The EP2 and EP4 agonists and antagonists induced and inhibited IL-6 expression. However, the EP4 agonist and antagonist were only observed to induce and inhibit IL-8 expression level. The Akt and NF-ΚB inhibitors significantly blocked PGE2-induced expression of IL-6 and IL-8. Conclusions: PGE2 increases IL-6 expression via EP2 and EP4 receptors, and IL-8 expression via the EP4 receptor in NPDFs. It also activates the Akt and NF-ΚB signal pathways for the production of IL-6 and IL-8 in NPDFs. These results suggest that signaling pathway for IL-6 and IL-8 expression induced by PGE2 might be a useful therapeutic target for the treatment of nasal polyposis.

KW - Akt

KW - E prostanoid receptor

KW - Interleukin-6

KW - Interleukin-8

KW - Nasal polyps

KW - Prostaglandins E

UR - http://www.scopus.com/inward/record.url?scp=84906956191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906956191&partnerID=8YFLogxK

U2 - 10.4168/aair.2014.6.5.449

DO - 10.4168/aair.2014.6.5.449

M3 - Article

VL - 6

SP - 449

EP - 457

JO - Allergy, Asthma and Immunology Research

JF - Allergy, Asthma and Immunology Research

SN - 2092-7355

IS - 5

ER -